Literature DB >> 26709109

The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective.

Gregorio T Obrador1, Ximena Rubilar2, Evandro Agazzi3, Janette Estefan4.   

Abstract

The costs of health care place developing countries under enormous economic pressure. Latin America is a region characterized by wide ethnic and per capita gross domestic product variations among different countries. Chronic kidney failure prevalence and incidence, as well as provision of renal replacement therapy (RRT), have increased in all Latin American countries over the last 20 years. From an ethical point of view, life-sustaining therapies such as RRT should be available to all patients with chronic kidney disease who might benefit. However, even among Latin American countries with similar per capita incomes and health care expenditures, only some have been able to achieve universal access to RRT. This indicates that it is not just a problem of wealth or distribution of scarce health care resources, but one of social justice. Strategies to increase the availability of RRT and renal palliative-supportive care, as well as implementation of interventions to prevent chronic kidney disease development and progression, are needed in Latin America and other developing countries.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Latin America; Renal replacement therapy (RRT); challenges; chronic kidney disease; developing countries; end-stage renal disease (ESRD); health care expenditures; health disparities; medical ethics

Mesh:

Year:  2015        PMID: 26709109     DOI: 10.1053/j.ajkd.2015.08.033

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Global Dialysis Perspective: Mexico.

Authors:  Enzo Vasquez-Jimenez; Magdalena Madero
Journal:  Kidney360       Date:  2020-04-20

2.  Is an Environmental Nephrotoxin the Primary Cause of CKDu (Mesoamerican Nephropathy)? Commentary.

Authors:  Magdalena Madero
Journal:  Kidney360       Date:  2020-06-17

Review 3.  Developing the ethical framework of end-stage kidney disease care: from practice to policy.

Authors:  Valerie A Luyckx; Dominique E Martin; Mohammed Rafique Moosa; Aminu K Bello; Ezequiel Bellorin-Font; Tak Mao Chan; Rolando Claure-Del Granado; Walter Douthat; Somchai Eiam-Ong; Felicia U Eke; Bak Leong Goh; Vivekanand Jha; Evie Kendal; Adrian Liew; Yewondwossen Tadesse Mengistu; Elmi Muller; Ikechi G Okpechi; Eric Rondeau; Manisha Sahay; Michele Trask; Tushar Vachharajani
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

4.  Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.

Authors:  Rafael Valdez-Ortiz; Francisco Navarro-Reynoso; Ma Guadalupe Olvera-Soto; Geovana Martin-Alemañy; Adrian Rodríguez-Matías; Clara Rocío Hernández-Arciniega; Mario Cortes-Pérez; Ernesto Chávez-López; Gloria García-Villalobos; Héctor Hinojosa-Heredia; Ana Yetzin Camacho-Aguirre; Ángel Valdez-Ortiz; Guillermo Cantú-Quintanilla; Irma Gómez-Guerrero; Arturo Reding; Monserrat Pérez-Navarro; Gregorio Obrador; Ricardo Correa-Rotter
Journal:  Kidney Int Rep       Date:  2018-06-20

5.  End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study.

Authors:  Ilais Moreno Velásquez; Maribel Tribaldos Causadias; Régulo Valdés; Beatriz Gómez; Jorge Motta; César Cuero; Víctor Herrera-Ballesteros
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

6.  Renal replacement therapy in intensive care units in KwaZulu-Natal Province, South Africa.

Authors:  D L Skinner; K de Vasconcellos; R Wise; T Kisten; M Faurie; T Hardcastle; D J J Muckart
Journal:  South Afr J Crit Care       Date:  2021-03-17

7.  Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

Authors:  Eugene Lin; Glenn M Chertow; Brandon Yan; Elizabeth Malcolm; Jeremy D Goldhaber-Fiebert
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

8.  Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies.

Authors:  Javier Roberti; Amanda Cummings; Michelle Myall; Jonathan Harvey; Kate Lippiett; Katherine Hunt; Federico Cicora; Juan Pedro Alonso; Carl R May
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

9.  LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.

Authors:  Roopa Mehta; Daniel Elías-López; Alexandro J Martagón; Oscar A Pérez-Méndez; Maria Luisa Ordóñez Sánchez; Yayoi Segura; Maria Teresa Tusié; Carlos A Aguilar-Salinas
Journal:  Lipids Health Dis       Date:  2021-07-13       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.